These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4413163)

  • 21. Effects of cytidine-diphosphocholine on acetylcholine-mediated behaviors in the rat.
    Drago F; Mauceri F; Nardo L; Valerio C; Genazzani AA; Grassi M
    Brain Res Bull; 1993; 31(5):485-9. PubMed ID: 8388315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diurnal rhythm in behavioral effects of methamphetamine, p-chloramethamphetamine and scopolamine.
    Evans HL; Ghiselli WB; Patton RA
    J Pharmacol Exp Ther; 1973 Jul; 186(1):10-7. PubMed ID: 4723307
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of scopolamine on acquisition of passive avoidance.
    Calhoun WH; Smith AA
    Psychopharmacologia; 1968 Sep; 13(3):201-9. PubMed ID: 5679625
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of molsidomine on scopolamine-induced amnesia and hypermotility in the rat.
    Pitsikas N; Rigamonti AE; Cella SG; Locatelli V; Sala M; Muller EE
    Eur J Pharmacol; 2001 Aug; 426(3):193-200. PubMed ID: 11527544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parallel but independent effects of pentobarbital and scopolamine on hippocampus-related behavior.
    Douglas RJ; Truncer PC
    Behav Biol; 1976 Nov; 18(3):359-67. PubMed ID: 1016176
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative effects of scopolamine and amphetamine upon behavioral reactivity and visual evoked potentials to flashes in rats.
    Schwartzbaum JS; Ide-Johanson L; Belgrade J
    J Comp Physiol Psychol; 1974 Jun; 86(6):1044-51. PubMed ID: 4836853
    [No Abstract]   [Full Text] [Related]  

  • 27. Task-dependent development of tolerance to scopolamine.
    Rosic N; Bokonjic D; Overstreet DH
    Pharmacol Biochem Behav; 1980 Aug; 13(2):183-6. PubMed ID: 7413688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Information content of rat scotophobin.
    Miller RR; Small D; Berk AM
    Behav Biol; 1975 Dec; 15(4):463-72. PubMed ID: 1239994
    [No Abstract]   [Full Text] [Related]  

  • 29. The effects of cholinergic agents upon fixated behavior.
    Houser VP; Feldman RS
    Psychopharmacologia; 1971; 21(2):147-56. PubMed ID: 5570195
    [No Abstract]   [Full Text] [Related]  

  • 30. Minaprine cancels scopolamine effects on the rat's acquisition of passive avoidance responses in two multitrial paradigms.
    Ambrogi Lorenzini C; Baldi E; Bucherelli C; Tassoni G
    Pharmacol Biochem Behav; 1992 Apr; 41(4):715-8. PubMed ID: 1594638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of OM-853, a cerebral metabolic ameliorator, on ambulatory activity and passive and active avoidance responses in mice and Mongolian gerbils.
    Saito T; Shuto K; Kuribara H; Tadokoro S
    Jpn J Pharmacol; 1993 Jun; 62(2):183-90. PubMed ID: 8371517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholinergic involvement in inhibitory behavior of the young domestic chick.
    Zolman JF; Mattingly BA; Sahley CL
    Behav Biol; 1978 Aug; 23(4):415-32. PubMed ID: 697692
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of systemic administration of beta-casomorphin-5 on learning and memory in mice.
    Sakaguchi M; Koseki M; Wakamatsu M; Matsumura E
    Eur J Pharmacol; 2006 Jan; 530(1-2):81-7. PubMed ID: 16360145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions of scopolamine and physostigmine with ECS and one trial learning.
    Davis JW; Thomas RK; Adams HE
    Physiol Behav; 1971 Mar; 6(3):219-22. PubMed ID: 5125477
    [No Abstract]   [Full Text] [Related]  

  • 35. An analysis of the facilitation of avoidance acquisition produced by d-amphetamine and scopolamine.
    Barrett RJ; Leith NJ; Ray OS
    Behav Biol; 1974 Jun; 11(2):189-203. PubMed ID: 4847521
    [No Abstract]   [Full Text] [Related]  

  • 36. The 5-HT(6) receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged rats.
    Foley AG; Murphy KJ; Hirst WD; Gallagher HC; Hagan JJ; Upton N; Walsh FS; Regan CM
    Neuropsychopharmacology; 2004 Jan; 29(1):93-100. PubMed ID: 14571256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-muscarinic drug effects in a swim-to-platform test: dose-response relations.
    Vanderwolf CH
    Behav Brain Res; 1991 Aug; 44(2):217-9. PubMed ID: 1751013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential attenuation of some effects of haloperidol in rats given scopolamine.
    Setler P; Sarau H; McKenzie G
    Eur J Pharmacol; 1976 Sep; 39(1):117-26. PubMed ID: 986946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of concurrent manipulations of nicotinic and muscarinic receptors on spatial and passive avoidance learning.
    Riekkinen P; Sirviö J; Aaltonen M; Riekkinen P
    Pharmacol Biochem Behav; 1990 Nov; 37(3):405-10. PubMed ID: 2087481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging cholinergic mechanisms and ontogeny of response inhibition in the mouse.
    Ray D; Nagy ZM
    J Comp Physiol Psychol; 1978 Apr; 92(2):335-49. PubMed ID: 670457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.